BN ImmunoTherapeutics Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

BN ImmunoTherapeutics General Information

Description

Developer and manufacturer of cancer vaccines. The company provides research services with focus on cancer vaccine.

Contact Information

Website
www.bn-immunotherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2425 Garcia Avenue
  • Mountain View, CA 94043
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 2425 Garcia Avenue
  • Mountain View, CA 94043
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BN ImmunoTherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BN ImmunoTherapeutics‘s full profile, request access.

Request a free trial

BN ImmunoTherapeutics Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

BN ImmunoTherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1641819-B1 Purification of her-2 variants Inactive 25-Jun-2003
EP-1641819-A1 Purification of her-2 variants Active 25-Jun-2003
ES-2325584-T3 Purification of variations of her-2. Inactive 25-Jun-2003
DE-602004020769-D1 Purification of her-2 variants Inactive 25-Jun-2003
CA-2530233-A1 Purification of her-2 variants Active 25-Jun-2003 C07K14/4705
To view BN ImmunoTherapeutics’s complete patent history, request access »

BN ImmunoTherapeutics FAQs

  • Where is BN ImmunoTherapeutics headquartered?

    BN ImmunoTherapeutics is headquartered in Mountain View, CA.

  • What industry is BN ImmunoTherapeutics in?

    BN ImmunoTherapeutics’s primary industry is Drug Discovery.

  • Is BN ImmunoTherapeutics a private or public company?

    BN ImmunoTherapeutics is a Private company.

  • What is the current valuation of BN ImmunoTherapeutics?

    The current valuation of BN ImmunoTherapeutics is .

  • What is BN ImmunoTherapeutics’s current revenue?

    The current revenue for BN ImmunoTherapeutics is .

  • How much funding has BN ImmunoTherapeutics raised over time?

    BN ImmunoTherapeutics has raised $15.5M.

  • When was BN ImmunoTherapeutics acquired?

    BN ImmunoTherapeutics was acquired on 11-Nov-2009.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »